Cargando…

Synthesis and testing of azaglutamine derivatives as inhibitors of Hepatitis A Virus (HAV) 3C proteinase

Hepatitis A virus (HAV) 3C proteinase is a picornaviral cysteine proteinase that is essential for cleavage of the initially synthesized viral polyprotein precursor to mature fragments and is therefore required for viral replication in vivo. Since the enzyme generally recognizes peptide substrates wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yanting, Malcolm, Bruce A, Vederas, John C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd. 1999
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172622/ https://www.ncbi.nlm.nih.gov/pubmed/10353640 http://dx.doi.org/10.1016/S0968-0896(99)00006-1

Ejemplares similares

An Episulfide Cation (Thiiranium Ring) Trapped in the Active Site of HAV 3C Proteinase Inactivated by Peptide-based Ketone Inhibitors
por: Yin, Jiang, et al.
Publicado: (2006)

Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action
por: Huitema, Carly, et al.
Publicado: (2008)

Hepatitis A virus (HAV) packaging size limit
por: Konduru, Krishnamurthy, et al.
Publicado: (2009)

Sporadic Hepatitis A Virus PCR False-Positive Results Observed during Reflex Testing of Serum Samples Previously Tested for Anti-HAV Antibodies and Caused by Contamination with HAV RNA Present in the Reagents of the Commercial Anti-HAV Immunoassay
por: Lunar, Maja M., et al.
Publicado: (2023)

Synthesis of Some New Pyridazine Derivatives for Anti-HAV Evaluation
por: Flefel, Eman M., et al.
Publicado: (2017)

Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase
por: Jorshari, Mehrnaz Rafiei, et al.
Publicado: (2021)

Prevalence of HAV and HEV in the patients presenting with acute viral hepatitis
por: Rao, Pooja, et al.
Publicado: (2012)

A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations
por: Konduru, Krishnamurthy, et al.
Publicado: (2008)

In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant
por: Zhu, Julie, et al.
Publicado: (2019)

Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health
por: Saberifiroozi, Mehdi
Publicado: (2011)

Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico
por: Carlos, Fernando, et al.
Publicado: (2015)

Sensory perception testing by monofilaments in the digits of controls and workers with HAVS
por: Poole, C. J. M., et al.
Publicado: (2020)

Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
por: Kankam, Martin, et al.
Publicado: (2020)

Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
por: Lu, Yiqi, et al.
Publicado: (1997)

Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
por: Zhang, Jianmin, et al.
Publicado: (2008)

Changes in hepatitis A virus (HAV) seroprevalence in medical students in Bangkok, Thailand, from 1981 to 2016
por: Sintusek, Palittiya, et al.
Publicado: (2018)

HAV Immunity in Iranian Medical Students
por: Hosseini Shokouh, Seyyed Javad, et al.
Publicado: (2015)

No IL-18BP? Avoid HAV
por: Diamond, Michael S.
Publicado: (2019)

HAV Infection Associated with Hemophagocytic Syndrome
por: Aamri, H., et al.
Publicado: (2023)

Nachrichten des Deutschen Hausärzteverbands (HÄV)
Publicado: (2023)

Acute bilateral granulomatous anterior uveitis as an extra-hepatic manifestation of hepatitis A virus (HAV) infection: a case report
por: Azimi, Ali, et al.
Publicado: (2020)

Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system
por: Nain, Anshu, et al.
Publicado: (2022)

A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice
por: Kui, Xiang, et al.
Publicado: (2017)

PROTEINASE INHIBITORS | Cystatins
por: Pemberton, P.A.
Publicado: (2006)

Natural Products and Their Potential Anti-HAV Activity
por: Jama-Kmiecik, Agnieszka, et al.
Publicado: (2021)

Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1)
por: dos Santos, Gabriel Menezes Costa, et al.
Publicado: (2021)

Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study
por: Amado Leon, Luciane Almeida, et al.
Publicado: (2015)

Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitis
por: Taubert, Richard, et al.
Publicado: (2018)

921. Acute HAV Infection in an Inpatient Psychiatry Unit
por: Weston, Gregory, et al.
Publicado: (2021)

Food-Borne Viruses in Shellfish: Investigation on Norovirus and HAV Presence in Apulia (SE Italy)
por: La Bella, G., et al.
Publicado: (2016)

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase
por: Gan, Yi-Ru, et al.
Publicado: (2006)

Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases
Publicado: (1988)

Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity
por: Davies, Philip L, et al.
Publicado: (2010)

Assessment of two alternative standardised tests for the vascular component of the hand–arm vibration syndrome (HAVS)
por: Ye, Ying, et al.
Publicado: (2016)

2193. Disparities in Hepatitis A Virus (HAV) Vaccination Coverage Among Adult Travelers to High-Risk Countries: The Role of Nativity and Race
por: Narayanan, Navaneeth, et al.
Publicado: (2018)

Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea
por: Lee, Sang Ho, et al.
Publicado: (2010)

Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors
por: Dubey, Amit, et al.
Publicado: (2023)

Cysteine proteinases of microorganisms and viruses
por: Rudenskaya, G. N., et al.
Publicado: (2011)

The HAV pattern in pediatric patients with atrioventricular node reentrant tachycardia
por: Moltedo, Jose M., et al.
Publicado: (2020)

Identifying inhibitors of the SARS coronavirus proteinase
por: Jenwitheesuk, Ekachai, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_4d32l99vf2ccs8av5ddcdmnuv9